Related Experiment Video
Updated: Sep 26, 2025

07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.3K
Biomimetic Nanoscale Materials for Skin Cancer Therapy and Detection
1Medical Engineering Department, Faculty of Engineering, Al-Ahliyya Amman University, Amman 19328, Jordan.
Journal of Skin Cancer
|April 18, 2022
Summary
This review explores nanotechnology for early skin cancer detection and treatment. It highlights advanced biosensors and discusses challenges for wider adoption of these innovative cancer therapies.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Skin cancer is a prevalent global health concern with significant economic and public health impacts.
- Nanotechnology offers promising solutions for targeted drug delivery in cancer therapy, minimizing side effects.
- Early diagnosis and effective treatment are crucial for managing skin cancer.
Purpose of the Study:
- To review current nanotechnology-based methods for early skin cancer diagnosis and treatment.
- To explore the application of various nanomaterials in skin cancer therapy.
- To discuss advancements in biosensors for skin cancer detection and management.
Main Methods:
- Review of existing literature on nanotechnology in skin cancer treatment.
- Analysis of traditional diagnostic methods and their limitations.
- Discussion of electrochemical and optical biosensors for skin cancer diagnosis.
Main Results:
- Nanomaterials show potential for effective drug delivery in skin cancer treatment.
- Biosensors offer improved methods for early skin cancer detection.
- Traditional diagnostic methods have limitations that innovative approaches aim to overcome.
Conclusions:
- Nanotechnology presents a significant field for advancing skin cancer treatment and diagnosis.
- Biosensors are key tools for prompt and accurate skin cancer identification.
- Addressing cost and usability challenges is vital for implementing novel skin cancer therapies.

